baber/WOPTO huggingface dataset:
Patent CA-2896731-A1 (CA)
Title: Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
Inventor: MALONEY DAVID J
IPC: A61K31/519
Filed: 2013-12-26
Abstract: Disclosed are inhibitors of the USP1/UAF1 deubiquitinase complex, for example. of formula (I), wherein R1, R2, and Q are as defined herein, which are useful in treating diseases such as cancer, and improving the efficacy of DNA damaging agents in cancer treatment. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, a method of method of inhibiting a heterodimeric deubiquitinase complex in a cell, and a method of enhancing the chemotherapeutic treatment of cancer in a mammal undergoing treatment with an anti cancer agent. Further disclosed is a method of preparing compounds of the invention.
Patent CA-2897910-A1 (CA)
Inventor: AKAMA TOSHIKAZU
IPC: H04N7/18
Filed: 2013-01-29
Abstract: A surveillance system 1, which is an example of a surveillance system to which the present invention is applied, includes a surveillance region storage means 2 and an image analyzing means 3. Also, the surveillance system 1 includes an effective area information storage means 4 and an object criterion information storage means 5. A detection subject can be detected efficiently by setting a first step criterion of whether or not a portion of an object in an image is included in a range of a surveillance region and a predetermined second step criterion and determining whether or not these criteria are met.
Patent CA-2897988-A1 (CA)
Title: Hybrid method for collision avoidance and object carrier management
Inventor: SACCO DANIEL
IPC: G01N35/02
Filed: 2014-01-16
Abstract: An automation system for use in in-vitro diagnostics includes an automation surface configured to provide one or more paths between a plurality of testing stations, which also includes a plurality of predetermined risk zones. A plurality of carriers include an onboard processor configured to make local trajectory decisions and to control the motion of each carrier into the plurality of predetermined risk zones in response to authority granted by a traffic manager. A traffic manager includes at least one processor configured to assign destinations to the plurality of carriers and grant authority to carriers to enter the plurality of predetermined risk zones. Each carrier can be configured to hold one or more fluid vessels and move the one or more fluid vessels to one of the plurality of testing stations.
Patent CA-2899866-A1 (CA)
Inventor: RUSNAK MATEJ
IPC: C09D7/61
Filed: 2013-12-30
Abstract: Material for surface treatment, mainly with thermo-reflexive and/or thermoinsulative characteristics, and with high water resistance level, contains first hollow glass bodies (1) with size fraction ranging from 65 to 110 pm, second, filler hollow glass bodies (2) intended to fill the spaces within main fraction of the bodies (1) and these second, filler hollowed glass bodies (2) have size fraction ranging from 30 to 105 pm, it also contains silicon dioxide processed to form of the nanopartlcles and a binder (3). Hollow glass bodies (1, 2) will be mainly shaped as hollow, vacuumed microballs. A mixture forming the material can contain hollow glass bodies (1) making up 3 to 30% of its mass, filler hollow glass bodies making up 3 to 15% of its mass and silicon dioxide making up 1 to 17% of its mass. The material for surface treatment is health friendly, it can be used especially on the house facades and in industry, where it is applied on the surface (4), the heath transfer and incandescence of which is to be diminished.
Patent CA-2900517-A1 (CA)
Inventor: KOGANOV MICHAEL
IPC: A61K36/48
Filed: 2014-03-10
Abstract: The present invention relates to a composition having enhanced anti-inflammatory properties and to a method for inhibiting inflammation in biological tissue, including but not limited to skin. Skin inflammation includes any undesirable effect produced in or on the surface of skin, including but not limited to irritation, redness, swelling, local temperature elevation, fissures, desquamation, itch, pain, sensitivity, abrasion, discoloration, and bleeding or the like, and combinations thereof. The invention demonstrates that certain plant fractions, such as the serum fractions of Camellia sinensis (Recentia® CS), Citrus limon (Recentia® CL), and Trifolium pratense (Recentia® TP), can be effectively utilized in various products to inhibit inflammation of biological tissue, including but not limited to skin. In one embodiment, said plant fractions have not undergone any significant fermentation.
Patent CA-2902227-A1 (CA)
Inventor: DESJARDIEN MATTHEW R
IPC: G05B19/408
Filed: 2014-05-02
Abstract: An apparatus and method for supporting an object. In one illustrative embodiment, an apparatus may comprise a support structure, a positioning system, and a retention system. The positioning system may be associated with the support structure and configured to position the support structure with respect to a number of linear axes. The retention system may be associated with the support structure. The retention system may be configured to retain a portion of an object and move the portion of the object towards a platform such that the portion of the object substantially conforms to a shape of the platform.
Patent CA-2903116-A1 (CA)
Title: Cyclone particulate filtration for lean burn engines
Inventor: PATCHETT JOSEPH A
IPC: F01N3/037
Filed: 2014-03-11
Abstract: Provided is a particulate filtration apparatus (10) for removing combustible and noncombustible particulate matter from a lean burn engine exhaust gas stream containing particulate matter. The apparatus comprises a cyclone body (20) with a roughened surface on the inner walls (40) designed to trap and agglomerate the combustible particulate matter. A catalyst, selected from a selective catalytic reduction catalyst, an ammonia oxidation catalyst, a hydrolysis catalyst, an oxidation catalyst, a three-way catalyst, and combinations thereof can be coated on the roughened surface. Also provided is a system and methods for treating an exhaust gas stream.
Patent CA-2903290-A1 (CA)
Inventor: ESQUENET MARC B
IPC: C02F1/68
Filed: 2014-03-05
Abstract: A composition for cleaning a medical instrument having a surface at least partially covered by a biofilm. The composition may include a first enzyme having a weight of less than about 10% of the total weight of the c omposition, a second enzyme having a weight of less than about 10% of the total weight of the composition, and a surfactant having a weight less than about 10% of the total weight of the composition. The second enzyme may be different from the first enzyme, Additionally, the composition may have a pH ranging from about 4 to about 12, and the composition may be configured to remove greater than about 90% of the biofilm from the medical instrument in less than about 10 minutes.
Patent CA-2907526-A1 (CA)
Inventor: MARTIN FRANCOIS-PIERRE
IPC: G01N33/48
Filed: 2014-03-13
Abstract: The present invention relates generally to the field of nutrition and health, particular, the present invention relates to alpha-keto-isovalerate as a biomarker urine of the efficacy of prebiotics for the prevention of diet induced weight gain.
Patent CA-2909457-A1 (CA)
Inventor: CORREIA VICTOR HUGO SILVA
IPC: F02C7/05
Filed: 2015-10-22
Abstract: An engine component for a turbine engine includes a particle collector having a substrate configured to retain at least some particles from a particle-laden stream passing through a portion of the engine. A fluid bypass around the substrate of the collector enables the particle-laden stream to bypass the substrate if the substrate is filled with particles.
Patent CA-2911878-A1 (CA)
Title: Data verification
Inventor: BIRDI SATNAM SINGH
IPC: G06F21/14
Filed: 2013-03-14
Abstract: Data verification is performed in a data communication system comprising a data verification provider server system (110) and user equipment (120). The user equipment potentially comprises malicious software element(s) (125) that can communicate data via a first channel (126). A second channel (129) is established separately from the first channel for communicating data with the data verification provider. Data identifying one or more algorithms to be used to derive output data from given input data is received via the second channel (129). The algorithm(s) are associated with a given data verification request from the data verification provider and vary between different data verification requests from the data verification provider. The algorithm(s) and received input data are used to derive output data. The output data is transmitted via the second channel (129). The data verification provider may compare the derived output data with expected output data for the given data verification request to determine a data verification result.
Patent CA-2913260-A1 (CA)
Title: Differential mapping of a body organ
Inventor: MERSCHON ASAF
IPC: A61B5/00
Filed: 2015-11-25
Abstract: A method for mapping a body organ, including receiving a three-dimensional (3D) map of the body organ having a multiplicity of map elements, each map element having a graphic attribute indicative of a local property of the body organ. The method further includes delineating a selected region of the map, so that the map is divided into the selected region and a non-selected region. The 3D map is displayed while the graphic attribute of the map elements specifically within the selected region are altered.
Patent CA-2915740-A1 (CA)
Inventor: JEONG HONG-SIL
IPC: H03M13/11
Filed: 2014-06-13
Abstract: La présente invention concerne un appareil de codage. L'appareil de codage comprend un codeur de contrôle de parité à faible densité (LDPC) qui effectue un codage LDPC sur des bits d'entrée sur la base d'une matrice de contrôle de parité afin de générer un mot de code LDPC formé de 64 800 bits, la matrice de contrôle de parité comprenant une sous-matrice de mot d'information et une sous-matrice de parité, la sous-matrice de mot d'information étant constituée d'un groupe d'une pluralité de blocs de colonnes comprenant chacun 360 colonnes, et la matrice de contrôle de parité et la sous-matrice de mot d'information étant définies au moyen de tables diverses représentant des positions de la valeur un (1) présente dans chaque 360ème colonne.
Patent CA-2918017-A1 (CA)
Inventor: KELLUM MATTHEW G
IPC: C04B28/02
Filed: 2013-09-04
Abstract: A cement composition including: a hydraulic cement; at least a sufficient concentration of water to form a pumpable slurry with the hydraulic cement; a polymer selected from the group consisting of: (i) a homopolymer of one monomer selected from the group consisting of: N isopropylacrylamide, N propylacrylamide, and N,N diethylacrylamide; (ii) a copolymer consisting of two or more monomers selected from the group consisting of: N isopropylacrylamide, N propylacrylamide, and N,N diethylacrylamide; and (iii) a copolymer comprising: one or more first monomers selected from the group consisting of: N isopropylacrylamide, N propylacrylamide, N,N diethylacrylamide, and any combination thereof; one or more second monomers selected from the group consisting of: acrylamide, an acrylamide derivative other than one of the first monomers, methacrylamide, an N alkylmethacrylamide, N-methyl-N-vinylacetamide, N-vinylformamide, a vinylpyrrolidone, a vinylpyridine, N-vinylcaprolactam, N-methyl-N-vinylacetamide, a styrene sulfonic acid, a styrenesulfonate, a vinylsulfonic acid, a vinylulfonate, and any combination thereof.
Patent CA-2919153-A1 (CA)
Inventor: MOSIER PATRICK E
IPC: C10M133/40
Filed: 2009-09-14
Abstract: The present Invention relates to the use of a compound in a lubricating composition as an engine oil antiwear and/or extreme pressure agent, wherein the compound is a heterocycle having a hydrocarbyl group containing 6 to 40 carbon atoms, wherein the heterocycle is either (i) a heterocycle compound having a functional group selected from the group consisting of at least one of an ester, an amide, a salt and an acid, or (ii) a pyrimidine.
Patent CA-2919262-A1 (CA)
Title: Systemes microfluidiques de culture cellulaire
Inventor: MAGDESIAN MARGARET HAIGANOUCH
IPC: C12N5/0793
Filed: 2014-07-29
Abstract: Puisque, dans le cas d'un grand nombre de systèmes physiologiques humains, des problèmes dans le système nerveux central peuvent survenir pour des individus, conduisant à une série de troubles neurologiques comprenant, sans y être limités, la maladie de Charcot-Marie-Tooth, la maladie d'Alzheimer, la maladie de Parkinson, la sclérose en plaques, la myasthénie grave, la démyélination et la dégénérescence axonale. Cependant, les dispositifs de culture imposent actuellement des limites aux chercheurs dans leurs recherches. Des modes de réalisation de l'invention visent à faire face à ces diverses limitations et permettent des études, des procédés et des criblages qui ne peuvent pas être réalisés avec des dispositifs de culture de l'état antérieur de la technique. Ils comprennent la réduction de la complexité de fabrication, la réduction des volumes nécessaires des produits pharmaceutiques et des cellules, permettent l'utilisation dans des domaines autres que la neurobiologie, une adhérence améliorée dans les zones souhaitées de microcanaux des dispositifs et augmentent la survie cellulaire dans les cultures. Conformément, l'invention concerne des dispositifs microfluidiques comprenant une chambre de liaison et un microcanal présentant la même profondeur qui empêche une pression hydrostatique, des parois terminales de la chambre de liaison et des séries de microcanaux présentant un angle élevé par rapport à la direction d'écoulement du fluide pour supporter la culture et la face du dessus de la chambre de liaison, qui a été profilée en vue d'améliorer l'adhérence des cellules.
Patent CA-2921600-A1 (CA)
Title: Systems and methods for drying roofs
Inventor: BURTON BRANDON
IPC: E04D13/04
Filed: 2016-02-23
Abstract: Roof drying processes and associated systems. A representative process includes drawing moisture-laden air from within the internal structure of a roof via a vacuum blower, a extraction insert and an extraction manifold, and removing moisture from the moisture-laden air via a dehumidifier. The dry air can be directed back into the roof through an injection insert and an injection manifold.
Patent CA-2924664-A1 (CA)
Title: Method for a targeted shaping of the magnetic field of permanent magnets
Inventor: DANIELI ERNESTO PABLO
IPC: H01F41/02
Filed: 2013-09-30
Abstract: The invention relates to a for a targeted shaping of the magnetic field of a single permanent magnet or an arrangement of a plurality of permanent magnets, wherein magnetic material from selected locations of the single permanent magnet or at least one of said permanent magnets of the arrangement is removed by means of at least one of the following removal procedures for shaping the magnetic field: laser ablation using laser radiation, high-pressure waterblasting using high-pressure water jets and mechanical ablation using a non-magnetic tool.
Patent CA-2925285-A1 (CA)
Inventor: GHOSH TIRTHANKAR
IPC: A23B7/144
Filed: 2014-09-19
Abstract: Provided are systems and methods for solvent-free delivery of volatile compounds, where an energy source is used to release the volatile compounds. The systems and methods provided herein have at least one advantage of (1) no solvent (for example water) is required; (2) immediate release of volatile compounds (for example 1-MCP can be released from HAIP within milliseconds or seconds instead of minutes or hours of the existing method using water); and/or (3) instantly starting and stopping the delivery of the volatile compound.
Patent CA-2926520-A1 (CA)
Inventor: GUZMAN Julio JAVIER
IPC: A47F8/02
Filed: 2016-04-08
Abstract: The invention pertains to upholstery techniques for upholstering the central bust line of mannequins. Particularly a shaping body is coupled to the central line of the upholstery and shaped to conform to the central bust line of an underlying mannequin form. The shaping body includes anchors, preferably, in the form of strings, which can be fed through the mannequin form and tensioned accordingly. The shaping body is preferably elongate with two identical body members coupled by a fold therebetween. The first body member is coupled to a first side of the central bust line seam of the upholstering covering and the second body member is coupled to the second side of the central bust line seam of the upholstering covering. The fold therebetween is shaped to conform to the shape of the central bust line of the mannequin form. The use of such a shaping body results in a natural convex curve of the central bust line.
Patent CA-2926527-A1 (CA)
Inventor: BOILARD ERIC
IPC: C12Q1/02
Filed: 2014-10-10
Abstract: The present disclosure highlights the relationship between extracellular mitochondrial components, optionally in combination with the secreted phospholipase A2-IIA and/or an auto-antibody, and in vivo as well as in vitro and inflammatory reactions/conditions, especially those released as a result of the degradation of a platelet. The present disclosure provides methods for determining the presence of inflammatory mediators, for limiting inflammatory reactions/conditions, for the diagnosis inflammatory reactions/conditions, for screening therapeutics for the treatment and/or the alleviation of symptoms of inflammatory reactions/conditions based on the detection or modulation of the level of these extracellular mitochondrial components.
Patent CA-2929690-A1 (CA)
Inventor: BADER YVES
IPC: F41H5/04
Filed: 2014-11-17
Abstract: The invention pertains to a composite wherein the composite comprises at least one fabric and a thermoplastic polymeric resin wherein the resin is impregnated into the fabric to an extent that between 80 to 95% of the maximum volumic mass (void volume) of the fabric is filled with resin. The fabric and thermoplastic resin are combined with one or two release layers to form an assembly. A plurality of these assemblies is combined to form a stack which is subjected to thermopressing wherein the thermopressing is carried out in at least two cycles with a pressure release between each cycle.
Patent CA-2930257-A1 (CA)
Inventor: HEFFNER GREG
IPC: H01B11/02
Filed: 2016-05-16
Abstract: A communications cable is provided having a jacket and a plurality of twisted pair, each twisted pair having two insulated conductors twisted around one another. The insulation on the insulated twisted conductors is foamed polysulfone.
Patent CA-2930972-A1 (CA)
Title: Signatures geniques pour pronostiquer un cancer du rein
Inventor: STONE STEVEN
IPC: C12Q1/68
Filed: 2014-12-04
Abstract: L'invention concerne des biomarqueurs et des méthodes utilisant lesdits biomarqueurs pour pronostiquer un cancer du rein chez un patient.
Patent CA-2931299-A1 (CA)
Inventor: STEVIS PANAYIOTIS
IPC: C07K16/28
Filed: 2014-11-20
Abstract: The present invention provides apelin receptor (APLNR) modulators that bind to APLNR and methods of using the same. The invention includes APLNR modulators such as antibodies, or antigen-binding fragments thereof, that inhibit or attenuate APLNR-mediated signaling. The invention includes APLNR modulators such as antibodies, or antibody fusion proteins thereof, that activate APLNR-mediated signaling. According to certain embodiments of the invention, the antibodies or antigen-binding fragments or antibody fusion proteins are fully human antibodies that bind to human APLNR with high affinity. The APLNR modulators of the invention are useful for the treatment of diseases and disorders associated with APLNR signaling and/or APLNR cellular expression, such as cardiovascular diseases, angiogenesis diseases, metabolic diseases and fibrotic diseases.
Patent CA-2932500-A1 (CA)
Inventor: HUFFER STEPHAN
IPC: C08B37/00
Filed: 2014-12-10
Abstract: The present invention relates to a modified polysaccharide obtainable by a process comprising the step of treating a polysaccharide with gaseous or liquid SO2, a laundry detergent composition comprising said modified polysaccharide, the use of said modified polysaccharide to increase whiteness of a washed fabric, the use of said modified polysaccharide as anti-greying agent in aqueous laundry processes, the use of said modified polysaccharide as a rheology modifier for homecare applications and the use of said modified polysaccharide in the manufacture of a liquid laundry composition. Further aspects of the invention are a method for preparing a laundry detergent composition comprising said modified polysaccharide.
Patent CA-2934120-A1 (CA)
Inventor: TYEBJI ZIAUDDIN
IPC: A61K9/20
Filed: 2014-12-19
Abstract: The present invention relates to solid particles of a poorly soluble drug, pharmaceutical compositions comprising them and processes for their preparation. The compositions according to the present invention show an improved dissolution profile while being stable.
Patent CA-2935874-A1 (CA)
Title: System and method for securing source routing using public key based digital signature
Inventor: WAN TAO
IPC: H04L45/42
Filed: 2015-02-09
Abstract: Embodiments are provided for securing source routing using public key based digital signature. If a protected source route is tampered with, a public key based method allows a downstream node to detect the tampering. The method is based on using digital signatures to protect the integrity of source routes. When creating a source route for a traffic flow, a designated network component computes a digital signature and adds the digital signature to the packets. When the packets are received at a node on the route, the node uses the digital signature and a public key to verify the source route and determines accordingly whether the source route has been tampered with. If tampering is detected, the receiving node stops the forwarding of the packets.
Patent CA-2937402-A1 (CA)
Title: Composition iota-carraghenane efficace contre la conjonctivite virale
Inventor: PRIESCHL-GRASSAUER EVA
IPC: A61K31/731
Filed: 2015-01-20
Abstract: La présente invention concerne une composition pharmaceutique pour utilisation en tant que médicament dans le traitement topique prophylactique ou thérapeutique d'infections oculaires virales causées par un adénovirus de sous-type D ou un virus de la grippe de sous-type H7. La composition dans sa formulation prête à l'usage comprend du carraghénane iota en tant que composant antiviral actif et est sensiblement exempte d'un sel d'halogénure de métal ou ne contient pas plus de 0,5 % m/v d'un sel d'halogénure de métal.
Patent CA-2938328-A1 (CA)
Inventor: JACKSON THOMAS JOSEPH JR
IPC: B62B1/18
Filed: 2016-08-05
Abstract: Exemplary embodiments of an expedition cart are provided. The expedition cart includes a chassis configured and dimensioned to support a load. The expedition cart includes first and second gusset plates attached to the chassis. Each of the first and second gusset plates includes a central body portion and curved fastening edges on either side of the central body portion. The curved fastening edges can be configured and dimensioned to mate against at least a portion of the chassis. Exemplary embodiments of an expedition cart are also provided that include first and second hubs engaged with the chassis, the first and second hubs defining either a single part or a two part design.
Patent CA-2938491-A1 (CA)
Title: Pressurised metered dose inhalers and method of manufacture
Inventor: TAYLOR GLYN
IPC: B65B31/00
Filed: 2015-02-12
Abstract: The invention relates to a method for the manufacture of a pressurised Metered Dose Inhaler (pMDI) and components for use in said method, in particular, a pMDI compatible tablet (i.e. one that is able to be dispersed or disintegrates within a liquid phase, such as a propellant, used in a pMDI formulation) which contains at least one active pharmaceutical ingredient (API) and, optionally, one or more excipients.